🇺🇸 FDA
Patent

US 8163709

TAK1-D mediated induction of cell death in human cancer cells by specific sequence short double-stranded RNAS

granted A61KA61K31/7105A61P

Quick answer

US patent 8163709 (TAK1-D mediated induction of cell death in human cancer cells by specific sequence short double-stranded RNAS) held by The Board of Regents of the University of Texas System expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/7105, A61P, A61P35/00